Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Tianeptine in the Treatment of Covid Fog Symptoms in Patients After COVID-19.
Clinical trial NCT06012552 · RECRUITING
Trial details
- NCT number
- NCT06012552
- Sponsor
- Military Institute od Medicine National Research Institute
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-17
- Primary completion
- 2027-04-30
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.